ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response.

Shilpak Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.